SH3D21 rs34416442 genetic variation is associated with pancreatic cancer patients’ overall survival and their response to gemcitabine

Masoudi, M. , , Ahangarian, N. , and Ammarlou, H. . "SH3D21 rs34416442 genetic variation is associated with pancreatic cancer patients’ overall survival and their response to gemcitabine", Molecular Biology Research Communications, , , 2026, 159-164. doi: 10.22099/mbrc.2026.55565.2273

Comments (0)

No login
gif